Magdent

Company Overview

Snapshot

Founded in May 2010 by Shlomo Barak and Moshe Neuman, Magdent operates with 11–50 employees. The company has raised $6.7 million across six funding rounds. In October 2022, Magdent secured funding from Catapult Education.

Business overview

Magdent is a Health Tech & Life Sciences company focused on revolutionizing dental implantology. The company develops innovative pulsed electromagnetic field (PEMF) healing abutments that integrate with standard implants to accelerate natural biological healing processes. Magdent's technology is designed to reduce inflammation, suppress peri-implantitis (a common cause of implant failure), stimulate bone formation, and improve tissue quality, thereby shortening recovery times by up to two-thirds. This technology is particularly beneficial for high-risk patients, such as heavy smokers, for whom traditional implants may be challenging. Magdent operates within the Medical Devices and Medical Treatment & Therapeutics sectors, serving the healthcare industry.

Strategic signal

Magdent's miniaturized electromagnetic devices (MEDs) are designed to stimulate bone formation and improve the quality of both hard and soft tissue, significantly shortening recovery time for dental implant patients. This innovation addresses a critical need in dental implantology by reducing inflammation and treating peri-implantitis, a condition affecting approximately 40% of implant procedures. The technology's ability to improve patient outcomes, especially for high-risk individuals, signals a strong potential for market disruption and cost savings for insurance providers, positioning Magdent as a key player in advancing dental care.

Company Intelligence Q&A

What is Magdent's core technology?

Magdent's core technology involves pulsed electromagnetic field (PEMF) healing abutments that work with standard dental implants to activate and accelerate the body's natural biological processes.

When was Magdent founded and by whom?

Magdent was founded in May 2010 by Shlomo Barak and Moshe Neuman.

What is the primary benefit of Magdent's technology for dental patients?

Magdent's technology aims to reduce inflammation, treat peri-implantitis, stimulate bone formation, and improve tissue quality, which can shorten recovery time for dental implant procedures by up to two-thirds.

What problem in dental implantology does Magdent's technology address?

Magdent's technology addresses peri-implantitis, a condition that occurs in about 40% of implant procedures and can lead to implant failure, by promoting bone growth and treating affected patients.